Samsung Bioepis CH GmbH - Byooviz 10 mg / mL, Injektionslösung in Durchstechflasche Swissmedic Registration 68690 Sequence 01 Product name Byooviz 10 mg / mL Description Injektionslösung in Durchstechflasche ATC-Classification S01LA04 ATC-Description Ranibizumab Introduction of Sequence 13.07.2022
Composition ranibizumabum 10 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml. Packungsbestandteile Galenic Form Injection solution Excipiens Active Agent Dose Ranibizumab 10 mg/ml
BAG: Active Agent Dose Ranibizumab 2.3 mg
Inactive agents Histidin Hydrochloride Monohydrate Histidine Polysorbatum 20 Trehalosum Dihydricum
Package number Package Size EFP CP Category SL Out of trade (MedRef) 001 555.54 620.60 B SL No 002 B Yes
